<DOC>
	<DOCNO>NCT01208922</DOCNO>
	<brief_summary>The purpose study prove non-inferiority Rifamycin SV-MMX® versus Ciprofloxacin treatment adult traveller 's diarrhoea .</brief_summary>
	<brief_title>Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules Acute Traveller 's Diarrhoea</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Dysentery</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Rifamycin SV</mesh_term>
	<criteria>Informed consent , Signs symptoms indication acute bacterial diarrhea ( traveller 's diarrhea ) Fever , Grossly bloody stool , Females pregnant breast feeding , Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>